Antigon | We revolutionize IVD testing
2
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,ajax_updown,page_not_loaded,,vertical_menu_enabled, vertical_menu_transparency vertical_menu_transparency_on,qode-title-hidden,paspartu_enabled,paspartu_on_top_fixed,paspartu_on_bottom_fixed,vertical_menu_inside_paspartu,side_area_uncovered_from_content,footer_responsive_adv,transparent_content,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

A new MedTech player in Immuno-Hematology and Tranfusion is born in Belgium to revolutionize IVD testing at bedside.

 

“Based on 2 patents from ULB, ANTIGON is currently developing, with a consortium of regional and international partners/subcontractors, a first disruptive ABO POCT device aiming to improve drastically transfusion safety at bedside.”